These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 955536

  • 1. [Polychemotherapy of the advanced and metastasizing carcinoma of the breast].
    Riedler L.
    Fortschr Med; 1976 May 06; 94(13):761-4. PubMed ID: 955536
    [Abstract] [Full Text] [Related]

  • 2. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW, Martz G, Senn HJ, Obrecht P, Alberto P, Melchert F.
    Internist (Berl); 1973 Dec 06; 14(12):643-52. PubMed ID: 4593011
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of hepatic metastases from breast cancer.
    Bugarski M, Vuletić L, Boberić J, Milosavljević A, Dilparić S, Tomin R, Naumović P.
    Clin Oncol; 1978 Jun 06; 4(2):167-71. PubMed ID: 668248
    [No Abstract] [Full Text] [Related]

  • 4. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT, Palshof T.
    Prog Clin Biol Res; 1977 Jun 06; 12():459-66. PubMed ID: 335404
    [No Abstract] [Full Text] [Related]

  • 5. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
    Byland W, Nagel G, Senn HJ.
    Schweiz Med Wochenschr; 1974 Aug 03; 104(31):1077-85. PubMed ID: 4445838
    [No Abstract] [Full Text] [Related]

  • 6. [Results of high-dosage attack treatment with cytostatics in mammary and ovarian cancer (author's transl)].
    Möhlen KH, Beller FK.
    Strahlentherapie; 1978 Sep 03; 154(9):622-6. PubMed ID: 684782
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Cytostatic therapy in metastasizing breast cancer].
    Gynning I, Mattsson W.
    Lakartidningen; 1978 Apr 12; 75(15):1512-5. PubMed ID: 651418
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Combination antimetabolite-alkylating agent-vinblastine in the treatment of advanced breast cancer].
    Pipino G, Germiniani R, Lavorato F.
    Minerva Med; 1977 Mar 17; 68(13):835-7. PubMed ID: 321990
    [Abstract] [Full Text] [Related]

  • 15. [218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
    Israel L, Bernard E.
    Poumon Coeur; 1968 Mar 17; 24(1):63-8. PubMed ID: 5690023
    [No Abstract] [Full Text] [Related]

  • 16. First, second and third line chemotherapy programs in metastatic breast carcinoma.
    Rizel S, Sulkes A, Gez E, Brufman G, Biran S.
    Isr J Med Sci; 1981 Mar 17; 17(9-10):946-53. PubMed ID: 6171542
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Chemotherapy of metastasizing breast cancers. Indications and results].
    Gallmeier WM, Bruntsch U, Schmidt CG.
    Dtsch Med Wochenschr; 1975 Jan 10; 100(2):35-41. PubMed ID: 1112210
    [Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience.
    Greenspan EM.
    Mt Sinai J Med; 1972 Jan 10; 39(5):435-46. PubMed ID: 4628078
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.